Patent · US Active

Delivery methods and compositions for nuclease-mediated genome engineering

US9957526B2 · kind B2 · utility

11Cited by
45References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2014
Grant dateMay 1, 2018
Priority date
Expiry dateOct 16, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.